The incidence of neonatal abstinence syndrome has been rising in the USA. Nonpharmacological treatments resulting in similar withdrawal states in the newborn have also been described. We report an infant with neonatal abstinence syndrome born to a mother with daily poppy seed tea ingestion for the self-treatment of nausea. A sample of poppy seed tea was replicated using the mother’s self-reported recipe. The sample was analyzed using liquid chromatography tandem mass spectrometry. This recipe produced a result of approximately 7.8 mg of morphine per serving which she reported to have drank 5–6 days per week, for an estimated 7 months during the course of her pregnancy.

1.
Hudak
ML
,
Tan
RC
;
COMMITTEE ON DRUGS
;
COMMITTEE ON FETUS AND NEWBORN
;
American Academy of Pediatrics
.
Neonatal drug withdrawal
.
Pediatrics
.
2012
Feb
;
129
(
2
):
e540
60
.
[PubMed]
0031-4005
2.
Maeda
A
,
Bateman
BT
,
Clancy
CR
,
Creanga
AA
,
Leffert
LR
.
Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes
.
Anesthesiology
.
2014
Dec
;
121
(
6
):
1158
65
.
[PubMed]
0003-3022
3.
Tolia
VN
,
Patrick
SW
,
Bennett
MM
,
Murthy
K
,
Sousa
J
,
Smith
PB
, et al
Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs
.
N Engl J Med
.
2015
May
;
372
(
22
):
2118
26
.
[PubMed]
0028-4793
4.
Patrick
SW
,
Davis
MM
,
Lehmann
CU
,
Cooper
WO
.
Increasing incidence and geographic distribution of neonatal abstinence syndrome: united States 2009 to 2012
.
J Perinatol
.
2015
Aug
;
35
(
8
):
650
5
.
[PubMed]
0743-8346
5.
Eldridge
WB
,
Foster
C
,
Wyble
L
.
Neonatal abstinence syndrome due to maternal kratom use
.
Pediatrics
.
2018
Dec
;
142
(
6
):
e20181839
.
[PubMed]
0031-4005
6.
Finnegan
LP
,
Connaughton
JF
 Jr
,
Kron
RE
,
Emich
JP
.
Neonatal abstinence syndrome: assessment and management
.
Addict Dis
.
1975
;
2
(
1-2
):
141
58
.
[PubMed]
0094-0267
7.
Powers
D
,
Erickson
S
,
Swortwood
MJ
.
Quantification of morphine, codeine, and thebaine in home-brewed poppy seed tea by LC-MS/MS
.
J Forensic Sci
.
2018
Jul
;
63
(
4
):
1229
35
.
[PubMed]
0022-1198
8.
Wolters Kuwler Clinical Drug Information, Inc. (Lexi-Drugs)
. Wolters Kluwer Clinical Drug Information, Inc.; September 12,
2019
. Accessed October 9, 2019.
9.
Haber
I
,
Pergolizzi
J
 Jr
,
LeQuang
JA
.
Poppy seed tea: a short review and case study
.
Pain Ther
.
2019
Jun
;
8
(
1
):
151
5
.
[PubMed]
2193-8237
10.
Sproll
C
,
Perz
RC
,
Lachenmeier
DW
.
Optimized LC/MS/MS analysis of morphine and codeine in poppy seed and evaluation of their fate during food processing as a basis for risk analysis
.
J Agric Food Chem
.
2006
Jul
;
54
(
15
):
5292
8
.
[PubMed]
0021-8561
11.
Braye
K
,
Harwood
T
,
Inder
R
,
Beasley
R
,
Robinson
G
.
Poppy seed tea and opiate abuse in New Zealand
.
Drug Alcohol Rev
.
2007
Mar
;
26
(
2
):
215
9
.
[PubMed]
0959-5236
12.
Poponea
N
,
Kashlan
MT
,
Vollstaedt
J
.
Opium poppy seed tea: a lesser known but deadly cocktail
.
Am J Respir Crit Care Med
.
2018
;
197
:
A6895
.1073-449X
13.
Lewis
RJ
,
Johnson
RD
,
Hattrup
RA
.
Simultaneous analysis of thebaine, 6-MAM and six abused opiates in postmortem fluids and tissues using Zymark automated solid-phase extraction and gas chromatography-mass spectrometry
.
J Chromatogr B Analyt Technol Biomed Life Sci
.
2005
Aug
;
822
(
1-2
):
137
45
.
[PubMed]
1570-0232
14.
Bailey
K
,
Richards-Waugh
L
,
Clay
D
,
Gebhardt
M
,
Mahmoud
H
,
Kraner
JC
.
Fatality involving the ingestion of phenazepam and poppy seed tea
.
J Anal Toxicol
.
2010
Oct
;
34
(
8
):
527
32
.
[PubMed]
0146-4760
15.
Spyres
MB
,
van Wijk
XM
,
Lapoint
J
,
Levine
M
.
Two cases of severe opiate toxicity after ingestion of poppy seed tea
.
Toxicol Commun
.
2018
;
2
(
1
):
102
4
. 2473-4306
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.